Reardon Andrew (CIK 1950232) reported 58 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy LGND (132 shares), Buy LGND (5,000 shares), Sell LGND (396 shares), Sell LGND (104 shares), Sell LGND (1,119 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 132 | $21,214 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 396 | $122,359 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 104 | $32,261 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,119 | $348,815 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,081 | $337,573 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 700 | $219,420 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 100 | $31,458 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 900 | $284,200 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 600 | $190,291 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 677 | $152,459 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 491 | $109,958 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,432 | $323,585 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 400 | $90,712 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 584 | $133,487 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,216 | $279,033 |
| 2026-06-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 200 | $46,082 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 460 | $91,471 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,302 | $260,038 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 1,238 | $248,767 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 700 | $141,328 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 963 | $195,703 |
| 2026-04-02 | LIGAND PHARMACEUTICALS INC (LGND) | CLO & Secretary | Sell | 337 | $68,917 |
Source: SEC Form 4 filings · as of 2026-07-06